In the Boardroom
Refine Search
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Biotechnology
A couple of additions have been made to the executive team of Orchard Therapeutics, a privately-held clinical-stage biotech based in the UK and USA. 21 March 2018
Biotechnology
Swedish biotech firm Karolinska Development's portfolio company Modus Therapeutics, which is focused on sickle cell disease (SCD) and malaria, announces that Dr John Öhd has been appointed to a position as chief medical officer (CMO). 15 March 2018
Pharmaceutical
A year after relinquishing the leadership of the UK’s leading drugmaker, Sir Andrew Witty has been named chief executive of a fast-growing player in the pharmacy benefit manager (PBM) space. 14 March 2018
Biotechnology
French biotech company Cellectis announced today that Dr Mathieu Simon is retiring as executive vice president and chief operating officer, effective immediately. 14 March 2018
Pharmaceutical
French drugmaker Ipsen has added two new names to its executive leadership team. 13 March 2018
Pharmaceutical
The departure of André Wyss, president of Novartis Operations, has prompted a series of structural and personnel changes at the top of the Swiss pharma major. 12 March 2018
Biotechnology
In what came as a surprise to most, Gilead Sciences announced today that Norbert Bischofberger has decided to step down from his role as executive vice president, R&D and chief scientific officer, effective at the end of April 2018. He will remain with the company through July. 12 March 2018
Pharmaceutical
Swiss pharma giant Roche today announced that Dr John Reed head of Roche Pharma Research and Early Development (pRED) since 2013, has decided to leave Roche for personal reasons and will return to the USA effective April 2, 2018. 9 March 2018
Pharmaceutical
James Kehoe, chief financial officer (CFO) of Takeda, is leaving his role with the Japanese pharma company to become global CFO of Walgreens Boots Alliance. 8 March 2018
Pharmaceutical
The president of Japanese drugmaker Takeda’s consumer healthcare business, Masashi Sugimoto, is to step down after a year in the role. 8 March 2018
Pharmaceutical
The new head of Santen Europe, Middle East and Africa (EMEA) is Luis Iglesias, the Japanese ophthalmology specialist has announced. 2 March 2018
Pharmaceutical
The head of Japanese pharma major Astellas’ (TYO: 4503) US operations is moving to take up a top position at US CNS focussed drugmaker Alkermes (Nasdaq: ALKS). 1 March 2018
Biotechnology
Experienced deal-maker Henrik Stenqvist will take over from retiring Mats-Olof Wallin to become the chief financial officer (CFO) of rare diseases specialist Swedish Orphan Biovitrum, the company has announced. 26 February 2018
Pharmaceutical
Ahead of next month’s annual general meeting, Danish diabetes giant Novo Nordisk has confirmed the recommendation that Helge Lund be named the new chairman of the board of directors. 23 February 2018
Biotechnology
Axovant Sciences today announced that its chief executive Officer David Hung has resigned to pursue other opportunities and has also resigned from the company’s board of directors. 12 February 2018
Biotechnology
Oxford, UK-based biotech Immunocore, the soluble TCR company developing first-in-class biologics that have the potential to transform patient lives, has announced that Dr Eliot Forster has stepped down as chief executive. 12 February 2018
Pharmaceutical
The man in charge at Amgen has been named the new chairman of the PhRMA board of directors for the year to come. 9 February 2018
Biotechnology
Just a month after Bo Jesper Hansen was named as chairman of the board of Belgian biotech Ablynx, his resignation has been announced. 7 February 2018
Pharmaceutical
As the US Centers for Disease Control and Prevention (CDC) struggles to manage the country’s worst flu outbreak in years, the agency suffered a blow Wednesday with the resignation of its director Brenda Fitzgerald. 2 February 2018
Pharmaceutical
Danish diabetes giant Novo Nordisk took a 6% hit in the stock market on Thursday morning after announcing results from the fourth quarter of 2017 along with the full-year figures. 1 February 2018
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze